Skip to content

Alexander Technique Neck Pain

Randomized Controlled Trial on the Efficacy of F.M. Alexander Technique in Chronic Neck Pain Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02209480
Acronym
ATNeck
Enrollment
72
Registered
2014-08-06
Start date
2007-12-31
Completion date
2008-08-31
Last updated
2018-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Non-specific Neck Pain

Brief summary

This study aimed to test the efficacy of five Alexander Technique lessons compared to the same period of heat pad application and guided imagery in patients with chronic non-specific neck pain.

Detailed description

see above

Interventions

DEVICEHeat pad application
BEHAVIORALguided imagery

Sponsors

Universität Duisburg-Essen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* chronic non-specific neck pain * at least 3 months * 40mm pain intensity on visual analog scale

Exclusion criteria

* neck pain as consequence of disc protrusion or prolapse, whiplash, congenital deformity of the spine, spinal stenosis, neoplasm, inflammatory rheumatic disease, neurological disorder, * active oncologic disease * affective disorder * addiction * psychosis. * pregnancy * invasive treatment of the spine within the previous three weeks * spinal surgery * previous experiences in Alexander Technique * ongoing application for disability pension * simultaneous participation in other clinical trials on neck pain

Design outcomes

Primary

MeasureTime frameDescription
neck pain intensity5 weeksneck pain intensity measured on a 100mm visual analog scales 1. comparison Alexander technique vs. heat pad 2. comparison Alexander technique vs. guided imagery

Secondary

MeasureTime frameDescription
Pain on motion5 weekspain on motion (movement of head in different directions) measured by the POM (Lauche, 2014, pain medicine)
Medication5 weeksweekly dose of medication calculated as the defined daily dose according to WHO
quality of life5 weeksquality of life measured by the SF-36 questionnaire
satisfaction5 weekssatisfaction measured on a visual analog scale and via questions like would you consider using it again or would you recommend it
safety5 weeksany adverse event during the study period
functional disability5 weeksmeasured by the neck disability index (NDI)

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026